HLUN.A
H. Lundbeck A/s
A Danish pharmaceutical company that focuses entirely on brain health, making treatments for conditions like depression, schizophrenia, and other central nervous system disorders—most famously the antidepressant escitalopram, sold as Lexapro in the US and Cipralex elsewhere. Founded in 1915 by Hans Lundbeck (whose surname means "lime grove stream"), the firm began as a Copenhagen trading house dealing in machinery, aluminium foil, and cosmetics before pivoting to medicines in the mid-20th century.
CINS: K4406L129HealthcareDK2 holders
Total Value
$6.77M
Total Shares
293.8K
Net Share Change
+9.6K
Activity
1 buying
Investor
Value
Shares
Weight
Change
